5//SEC Filing
AIRWARE LABS CORP. 5
Accession 0001554795-16-000939
CIK 0001500123operating
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 12:21 PM ET
Size
9.2 KB
Accession
0001554795-16-000939
Insider Transaction Report
Form 5
COHEN DANIEL E MD
DirectorPresident
Transactions
- Award
Common Stock
2016-09-27$0.08/sh+434,000$33,852→ 434,000 total
Holdings
- 166,667
Option
Exercise: $0.25From: 2016-08-17Exp: 2025-08-17→ Common Stock (166,667 underlying) - 333,333
Option
Exercise: $0.25From: 2017-08-17Exp: 2025-08-17→ Common Stock (166,666 underlying) - 500,000
Option
Exercise: $0.25From: 2018-08-17Exp: 2025-08-17→ Common Stock (166,667 underlying)
Footnotes (2)
- [F1]Dr. Daniel Cohen acquired 434,000 shares of common stock at a cost basis of $0.078 shares directly from the Issuer pursuant to a Debt Conversion Agreement dated September 26, 2016.
- [F2]On August 17, 2015, Dr. Daniel E. Cohen was appointed as President and director of Airware Labs Corp. Additionally, Dr. Cohen was issued a total of 500,000 options that vest over the next three years and are exercisable at the price of $0.25 per share.
Documents
Issuer
AIRWARE LABS CORP.
CIK 0001500123
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001500123
Filing Metadata
- Form type
- 5
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 12:21 PM ET
- Size
- 9.2 KB